Edwin Moses

Edwin Moses

Voorzitter bij AVANTIUM N.V.

Vermogen: 787 032 $ op 31-05-2024

69 jaar
Health Technology
Commercial Services
Finance

Profiel

Edwin Moses is currently the Chairman-Supervisory Board at Avantium NV since 2019.
He is also the Chairman at Achilles Therapeutics UK Ltd.
since 2018, LabGenius Ltd.
since 2020, Achilles Therapeutics Plc, Oak Hill Bio Corp.
since 2022, and Operating Partner at Keensight Capital SAS since 2020.
In his former roles, Dr. Moses served as the Chief Executive Officer & Director at Ablynx NV from 2014 to 2018.
He was also the Chairman at Capricorn Partners NV from 2009 to 2011, Galapagos Biotech Ltd.
from 2001 to 2006, and Oxford Asymmetry International Plc from 1993 to 2001.
Additionally, he held positions such as Non-Executive Chairman at Phoqus Pharmaceuticals Plc, ClinPhone Ltd., Noapab Holdings A, Paradigm Therapeutics Ltd.
from 2004 to 2007, Lectus Therapeutics Ltd., Pharmaceutical Profiles Group Ltd.
from 2005 to 2010, Proimmune Ltd., Sensorion SA from 2020 to 2021, and Evox Therapeutics Ltd.
from 2018 to 2020.
He also served as a Non-Executive Director at Fusion IP Ltd.
in 2009 and as a Director at Hammersmith Imanet Ltd.
from 1999 to 2000.
Dr. Moses was a Director at Evotec SE, Ionix Pharmaceuticals Ltd., Avantium Technologies BV, Oxford Drug Design Ltd.
from 2001 to 2002, The London Technology Network in 2002, ProPharma Ltd., Prolysis Ltd., Capricorn Health-Tech Fund NV from 2011 to 2016, European Biopharmaceutical Enterprises, AMS Biotechnology Ltd.
in 1993, and Principal at GE Healthcare Ltd.
(United Kingdom).
Dr. Moses obtained his undergraduate and doctorate degrees from The University of Sheffield.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
10-05-2023 202 934 ( 0.25% ) 565 082 $ 31-05-2024
01-02-2023 241 250 ( 0.59% ) 221 950 $ 31-05-2024

Actieve functies van Edwin Moses

BedrijvenFunctieBegin
AVANTIUM N.V. Voorzitter 20-12-2019
ACHILLES THERAPEUTICS PLC Voorzitter -
Voorzitter 10-12-2018
Voorzitter 20-04-2020
Private Equity Investor 02-06-2020
Voorzitter 12-04-2022
Alle actieve functies van Edwin Moses

Eerdere bekende functies van Edwin Moses

BedrijvenFunctieEinde
SENSORION Voorzitter 19-12-2021
Voorzitter 14-05-2020
ABLYNX Algemeen Directeur 01-06-2018
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Edwin Moses in detail bekijken

Opleiding van Edwin Moses

The University of Sheffield Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Edwin Moses in detail bekijken

Connecties

100 +

Eerstegraads connecties

35

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven5
EVOTEC SE

Health Technology

AVANTIUM N.V.

Producer Manufacturing

SENSORION

Health Technology

Wereld

Health Technology

ACHILLES THERAPEUTICS PLC

Health Technology

Bedrijven in privébezit29

Commercial Services

Health Technology

Finance

Hammersmith Imanet Ltd.

Health Technology

Oxford Asymmetry International Plc

Process Industries

Health Technology

Health Services

Commercial Services

Noapab Holdings A/S

Commercial Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Technology Services

Commercial Services

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

AMS Biotechnology Ltd.

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Edwin Moses